Early Effects of Rhodomyrtone on Membrane Integrity in Methicillin-Resistant Staphylococcus aureus

Wipawadee Sianglum1, Dennapa Saeloh2, Pongsri Tongtawe3

  • 11 Department of Microbiology and Excellence Research Laboratory on Natural Products, Faculty of Science and Natural Product Research Center of Excellence, Prince of Songkla University , Hat Yai, Thailand .

Microbial Drug Resistance (Larchmont, N.Y.)
|December 8, 2017
PubMed

Insights

Rhodomyrtone damages bacterial cell membranes, offering a new approach against drug-resistant bacteria. This study reveals its early membrane-disrupting effects on methicillin-resistant Staphylococcus aureus (MRSA).

Area of Science:

  • Microbiology
  • Pharmacology
  • Biochemistry

Background:

  • Previous work demonstrated rhodomyrtone's high potency against pathogenic gram-positive bacteria.
  • Multidrug-resistant bacteria, like methicillin-resistant Staphylococcus aureus (MRSA), pose a significant global health threat.

Purpose of the Study:

  • To investigate the early mechanisms of rhodomyrtone-induced membrane damage in MRSA.
  • To elucidate the action of rhodomyrtone, an acylphloroglucinol, on bacterial membrane integrity.

Main Methods:

  • Time-course studies using flow cytometry to assess membrane integrity.
  • Measurement of intracellular adenosine triphosphate (ATP) and potassium ion (K+) leakage.
  • Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) for ultrastructural analysis.

Main Results:

  • Rhodomyrtone treatment led to increased propidium iodide uptake and reduced green fluorescent emission in MRSA cells in a dose- and time-dependent manner.
  • Significant leakage of ATP and K+ from MRSA cells was observed, along with a decrease in intracellular ATP.
  • Microscopy revealed bacterial cell disruption, surface holes, and bulge formations in rhodomyrtone-treated MRSA.

Conclusions:

  • Rhodomyrtone acts as a bacterial cell membrane-damaging agent.
  • The primary early effect of rhodomyrtone involves disruption of the bacterial membrane.
  • Rhodomyrtone shows potential as a novel antibacterial agent targeting membrane integrity.